Application of an improved enzyme-linked immunosorbent assay method for serological diagnosis of canine leishmaniasis

Journal of Clinical Microbiology

Volumn 48, Issue 5, 2010, Pages 1866-1874

  Santarém, Nuno ^a   Silvestre, Ricardo ^a   Cardoso, Luís ^a,c   Schallig, Henk ^d   Reed, Steven G ^e   Cordeiro da Silva, Anabela ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^d ROYAL TROPICAL INSTITUTE   (Netherlands)

^e INFECTIOUS DISEASE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXIDASE; PROTOZOON ANTIBODY; RECOMBINANT PROTEIN;

AMASTIGOTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL DOG; LEISHMANIA DONOVANI; LEISHMANIASIS; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; SENSITIVITY AND SPECIFICITY; SEROLOGY;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; DOG DISEASES; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOGLOBULIN G; LEISHMANIA INFANTUM; LEISHMANIASIS; PARASITOLOGY; PEROXIDASES; PROTOZOAN PROTEINS; SENSITIVITY AND SPECIFICITY;

CANIS FAMILIARIS; LEISHMANIA INFANTUM;

EID: 77951783796     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02402-09     Document Type: Article

References (40)

1. Alvar, J., C. Canavate, R. Molina, J. Moreno, and J. Nieto. 2004. Canine leishmaniasis. Adv. Parasitol. 57:1-88.
2. Ashford, R. W. 1996. Leishmaniasis reservoirs and their significance in control. Clin. Dermatol. 14:523-532.
3. Badaro, R., D. Benson, M. C. Eulalio, M. Freire, S. Cunha, E. M. Netto, D. Pedral-Sampaio, C. Madureira, J. M. Burns, R. L. Houghton, J. R. David, and S. G. Reed. 1996. rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis. J. Infect. Dis. 173:758-761.
4. Baneth, G., A. F. Koutinas, L. Solano-Gallego, P. Bourdeau, and L. Ferrer. 2008. Canine leishmaniosis-new concepts and insights on an expanding zoonosis: part one. Trends Parasitol. 24:324-330.
5. Bern, C., J. H. Maguire, and J. Alvar. 2008. Complexities of assessing the disease burden attributable to leishmaniasis. PLoS Negl. Trop. Dis. 2:e313.
6. Burns, J. M., Jr., W. G. Shreffler, D. R. Benson, H. W. Ghalib, R. Badaro, and S. G. Reed. 1993. Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis. Proc. Natl. Acad. Sci. U. S. A. 90:775-779.
7. Cardoso, L., H. D. Schallig, A. Cordeiro-da-Silva, M. Cabral, J. M. Alunda, and M. Rodrigues. 2007. Anti-Leishmania humoral and cellular immune responses in naturally infected symptomatic and asymptomatic dogs. Vet. Immunol. Immunopathol. 117:35-41.
8. Castro, H., C. Sousa, M. Santos, A. Cordeiro-da-Silva, L. Flohe, and A. M. Tomas. 2002. Complementary antioxidant defense by cytoplasmic and mitochondrial peroxiredoxins in Leishmania infantum. Free Radic. Biol. Med. 33:1552-1562. (Pubitemid 35351599)
9. Chappuis, F., S. Sundar, A. Hailu, H. Ghalib, S. Rijal, R. W. Peeling, J. Alvar, and M. Boelaert. 2007. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat. Rev. Microbiol. 5:873-882.
10. Cordeiro-da-Silva, A., L. Cardoso, N. Araujo, H. Castro, A. Tomas, M. Rodrigues, M. Cabral, B. Vergnes, D. Sereno, and A. Ouaissi. 2003. Identification of antibodies to Leishmania silent information regulatory 2 (SIR2) protein homologue during canine natural infections: pathological implications. Immunol. Lett. 86:155-162.
11. Dantas-Torres, F. 2007. The role of dogs as reservoirs of Leishmania parasites, with emphasis on Leishmania (Leishmania) infantum and Leishmania (Viannia) braziliensis. Vet. Parasitol. 149:139-146. (Pubitemid 47498733)
12. Day, M. J. 2007. Immunoglobulin G subclass distribution in canine leishmaniosis: a review and analysis of pitfalls in interpretation. Vet. Parasitol. 147:2-8.
13. Dujardin, J. C., L. Campino, C. Canavate, J. P. Dedet, L. Gradoni, K. Soteriadou, A. Mazeris, Y. Ozbel, and M. Boelaert. 2008. Spread of vectorborne diseases and neglect of leishmaniasis, Europe. Emerg. Infect. Dis. 14:1013-1018.
14. Franca-Silva, J. C., R. T. da Costa, A. M. Siqueira, G. L. Machado-Coelho, C. A. da Costa, W. Mayrink, E. P. Vieira, J. S. Costa, O. Genaro, and E. Nascimento. 2003. Epidemiology of canine visceral leishmaniosis in the endemic area of Montes Claros Municipality, Minas Gerais State, Brazil. Vet. Parasitol. 111:161-173.
15. Gomes, Y. M., M. Paiva Cavalcanti, R. A. Lira, F. G. Abath, and L. C. Alves. 2008. Diagnosis of canine visceral leishmaniasis: biotechnological advances. Vet. J. 175:45-52. (Pubitemid 351187518)
16. Goto, Y., R. F. Howard, A. Bhatia, J. Trigo, M. Nakatani, E. M. Netto, and S. G. Reed. 2009. Distinct antigen recognition pattern during zoonotic visceral leishmaniasis in humans and dogs. Vet. Parasitol. 160:215-220.
17. Hassan, M. M., O. F. Osman, F. M. El-Raba'a, H. D. Schallig, and D. E. Elnaiem. 2009. Role of the domestic dog as a reservoir host of Leishmania donovani in eastern Sudan. Parasit. Vectors 2:26.
18. Herwaldt, B. L. 1999. Leishmaniasis. Lancet 354:1191-1199.
19. Jones, C. M., and T. Athanasiou. 2005. Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests. Ann. Thorac. Surg. 79:16-20.
20. Noya, O., M. E. Patarroyo, F. Guzman, and B. Alarcon de Noya. 2003. Immunodiagnosis of parasitic diseases with synthetic peptides. Curr. Protein Pept. Sci. 4:299-308.
21. Oliveira, C., M. Morais, and G. Machado-Coelho. 2008. Visceral leishmaniasis in large Brazilian cities: challenges for control. Cad. Saude Publica 24:2953-2958.
22. Porrozzi, R., M. V. Santos da Costa, A. Teva, A. Falqueto, A. L. Ferreira, C. D. dos Santos, A. P. Fernandes, R. T. Gazzinelli, A. Campos-Neto, and G. Grimaldi, Jr. 2007. Comparative evaluation of enzyme-linked immunosorbent assays based on crude and recombinant leishmanial antigens for sero-diagnosis of symptomatic and asymptomatic Leishmania infantum visceral infections in dogs. Clin. Vaccine Immunol. 14:544-548.
23. Quinnell, R. J., O. Courtenay, L. M. Garcez, P. M. Kaye, M. A. Shaw, C. Dye, and M. J. Day. 2003. IgG subclass responses in a longitudinal study of canine visceral leishmaniasis. Vet. Immunol. Immunopathol. 91:161-168.
24. Reithinger, R., and J. C. Dujardin. 2007. Molecular diagnosis of leishmaniasis: current status and future applications. J. Clin. Microbiol. 45:21-25.
25. Rhalem, A., H. Sahibi, N. Guessous-Idrissi, S. Lasri, A. Natami, M. Riyad, and B. Berrag. 1999. Immune response against Leishmania antigens in dogs naturally and experimentally infected with Leishmania infantum. Vet. Parasitol. 81:173-184. (Pubitemid 29099830)
26. Ribeiro, F. C., O. S. A. de, E. Mouta-Confort, T. M. Schubach, M. de Fatima Madeira, and M. C. Marzochi. 2007. Use of ELISA employing Leishmania (Viannia) braziliensis and Leishmania (Leishmania) chagasi antigens for the detection of IgG and IgG1 and IgG2 subclasses in the diagnosis of American tegumentary leishmaniasis in dogs. Vet. Parasitol. 148:200-206.
27. Rodriguez-Cortes, A., H. Fernandez-Bellon, A. Ramis, L. Ferrer, J. Alberola, and L. Solano-Gallego. 2007. Leishmania-specific isotype levels and their relationship with specific cell-mediated immunity parameters in canine leishmaniasis. Vet. Immunol. Immunopathol. 116:190-198.
28. Santarem, N., A. Tomas, A. Ouaissi, J. Tavares, N. Ferreira, A. Manso, L. Campino, J. M. Correia, and A. Cordeiro-da-Silva. 2005. Antibodies against a Leishmania infantum peroxiredoxin as a possible marker for diagnosis of visceral leishmaniasis and for monitoring the efficacy of treatment. Immunol. Lett. 101:18-23.
29. Scalone, A., R. De Luna, G. Oliva, L. Baldi, G. Satta, G. Vesco, W. Mignone, C. Turilli, R. R. Mondesire, D. Simpson, A. R. Donoghue, G. R. Frank, and L. Gradoni. 2002. Evaluation of the Leishmania recombinant K39 antigen as a diagnostic marker for canine leishmaniasis and validation of a standardized enzyme-linked immunosorbent assay. Vet. Parasitol. 104:275-285.
30. Schallig, H. D., M. Canto-Cavalheiro, and E. S. da Silva. 2002. Evaluation of the direct agglutination test and the rK39 dipstick test for the sero-diagnosis of visceral leishmaniasis. Mem. Inst. Oswaldo Cruz 97:1015-1018.
31. Schallig, H. D., E. S. da Silva, W. F. van der Meide, G. J. Schoone, and C. M. Gontijo. 2007. Didelphis marsupialis (common opossum): a potential reservoir host for zoonotic leishmaniasis in the metropolitan region of Belo Horizonte (Minas Gerais, Brazil). Vector Borne Zoonotic Dis. 7:387-393.
32. Schallig, H. D., G. J. Schoone, C. C. Kroon, A. Hailu, F. Chappuis, and H. Veeken. 2001. Development and application of "simple" diagnostic tools for visceral leishmaniasis. Med. Microbiol. Immunol. 190:69-71.
33. Schoone, G. J., A. Hailu, C. C. Kroon, J. L. Nieuwenhuys, H. D. Schallig, and L. Oskam. 2001. A fast agglutination screening test (FAST) for the detection of anti-Leishmania antibodies. Trans. R. Soc. Trop. Med. Hyg. 95:400-401.
34. Sereno, D., and J. L. Lemesre. 1997. Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents. Antimicrob. Agents Chemother. 41:972-976.
35. Silvestre, R., N. Santarem, J. Cunha, L. Cardoso, J. Nieto, E. Carrillo, J. Moreno, and A. Cordeiro-da-Silva. 2008. Serological evaluation of experimentally infected dogs by LicTXNPx-ELISA and amastigote-flow cytometry. Vet. Parasitol. 158:23-30.
36. Singh, S., A. Dey, and R. Sivakumar. 2005. Applications of molecular methods for Leishmania control. Expert Rev. Mol. Diagn. 5:251-265.
37. van der Meide, W., J. Guerra, G. Schoone, M. Farenhorst, L. Coelho, W. Faber, I. Peekel, and H. Schallig. 2008. Comparison between quantitative nucleic acid sequence-based amplification, real-time reverse transcriptase PCR, and real-time PCR for quantification of Leishmania parasites. J. Clin. Microbiol. 46:73-78.
38. van der Meide, W. F., G. J. Schoone, W. R. Faber, J. E. Zeegelaar, H. J. de Vries, Y. Ozbel, A. F. R. F. Lai, L. I. Coelho, M. Kassi, and H. D. Schallig. 2005. Quantitative nucleic acid sequence-based assay as a new molecular tool for detection and quantification of Leishmania parasites in skin biopsy samples. J. Clin. Microbiol. 43:5560-5566.
39. Walter, S. D. 2002. Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat. Med. 21:1237-1256.
40. Zweig, M. H., and G. Campbell. 1993. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 39:561-577.